Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Candace Makeda Moore"'
Publikováno v:
The American Journal of Cardiology. 170:128-131
Empagliflozin and oral semaglutide reduce the incidence of cardiovascular mortality (CVM) in patients with type 2 diabetes mellitus. However, these therapies impose a significant financial burden on healthcare systems. Therefore, we compared the valu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8d54a81d6bf480512f7095122c9e80f
https://doi.org/10.1016/j.amjcard.2022.01.027
https://doi.org/10.1016/j.amjcard.2022.01.027
Publikováno v:
American Journal of Infection Control
Background : Israel began a mass vaccination program with the rapid rollout of the Pfizer-BioNTech COVID-19 BNT162b2 vaccine for adults. At the same time, government stringency measures in terms of closing public life were decreased. Our objective wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a14a72ea22eb050cf68d100588d578c
https://doi.org/10.1016/j.ajic.2021.12.019
https://doi.org/10.1016/j.ajic.2021.12.019
Publikováno v:
Postgraduate medicine. 134(7)
Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP1a), reduces the risk of major adverse cardiovascular events (MACE) in patients with Type 2 diabetes mellitus (T2DM). An oral version of semaglutide is now available, and patients may prefer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d4f7b46887c8f3efa21e66730e980a6
https://pubmed.ncbi.nlm.nih.gov/35701876
https://pubmed.ncbi.nlm.nih.gov/35701876
BackgroundIn December 2020, Israel began a mass vaccination program with the rapid rollout of the Pfizer-BioNTech COVID-19 BNT162b2 vaccine for adults in Israel. The campaign vaccinated fewer people than necessary for herd immunity. However, at the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ea6e633b59c89db22e6353797212298
https://doi.org/10.1101/2021.10.27.21265591
https://doi.org/10.1101/2021.10.27.21265591
BackgroundIn 2021 a new variant of SARS-CoV-2, which came to be called the alpha variant, spread around the world. There were conflicting reports on this COVID-19 variant strain’s potentially increased lethality. In Israel, this strain became predo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bb30f3fe945c6bbdf58f0358d9994ef
https://doi.org/10.1101/2021.08.17.21262167
https://doi.org/10.1101/2021.08.17.21262167
Publikováno v:
Journal of Open Source Software. 7:3632
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::295f890e2b9e69986c1dec2e54c739ac
https://doi.org/10.21105/joss.03632
https://doi.org/10.21105/joss.03632
Autor:
Candace Makeda Moore
Publikováno v:
Intelligence-Based Medicine. 6:100067
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acaf4c29c4c97dc3c8d4190d71f16b23
https://doi.org/10.1016/j.ibmed.2022.100067
https://doi.org/10.1016/j.ibmed.2022.100067